Prognostic Factors and Optimal Response Interval for Stereotactic Body Radiotherapy in Patients With Lung Oligometastases or Oligoprogression From Colorectal Cancer

Frontiers in Oncology - Switzerland
doi 10.3389/fonc.2019.01080